|
|
|
European Pharmaceutical Contractor
|
Advancements in science and technology – coupled with rising R&D activities – and the increasing automation of laboratories and stringency of regulatory requirements are all resulting in the generation of a large volume of scientific data from R&D, manufacturing and quality assurance processes. As a consequence, there is a growing need for life sciences firms to efficiently manage large volumes of information; enhance connectivity and productivity; comply with strict regulations; survive swelling commercial pressures; and improve quality and operational efficacy. In short, the demand for effective data management solutions such as lab informatics has increased. This is particularly pronounced in labs engaged in collecting, analysing and mining experimental information in highly automated environments.
The evolution of informatics has culminated in the development of various systems with diverse capabilities, such as:
- Lab information management systems (LIMS)
- Electronic data capture (EDC)
- Clinical data management systems (CDMS)
- Electronic lab notebooks (ELN)
- Lab execution systems (LES)
- Scientific data management systems (SDMS)
- Chromatography data systems (CDS)
- Enterprise content management (ECM)
These solutions include a number of software platforms that help automate and accelerate R&D processes; assist in tracking samples; streamline information exchange with equipment; track lab procedures; reduce turnaround time; and ensure compliance with Good Laboratory Practice standards and FDA regulations.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
rfxcel Covers the Cost of EMVO Onboarding Fees
May 23, 2018 - San Ramon, CA – rfxcel Corporation, a technically certified Gateway Provider for the European Medicines Verification Organisation (EMVO) announced today that it will pay the cost of statutory fees payable to EMVO* for all manufacturers (Marketing Authorisation Holders, MAHs) which select rfxcel as their Gateway Provider before June 15th 2018.
More info >> |
|
 |
White Papers |
 |
|
Case Study: Molly™ Auto Injector
SHL Group
The Molly™ Auto Injector is a revolutionary, ultra-compact device, designed for convenience and portability. With the handling process reduced to only 2 simple steps— uncap and inject — Molly™ is incredibly intuitive to use, and quickly became a new benchmark for the auto injector industry. In addition to the many enhanced features that benefit patients, Molly™ was also uniquely designed to offer an alternative business model for customers, one that allowed them to minimize initial investments while maximizing speed-to-market.
More info >> |
|
 |
Industry Events |
 |
RDD Asia 2018
14-15 November 2018, Grand Hyatt Kochi, Kerala, India
A
must-attend meeting for pulmonary and nasal researchers, inhaled product
developers and vendors active in this important pharmaceutical niche.
More info >> |
|
|
